Semaglutide is a GLP-1 receptor agonist that mimics the naturally occurring hormone glucagon-like peptide-1, while tirzepatide is a dual GIP/GLP-1 receptor agonist that acts on two incretin hormone pathways
Clinicaltrials.gov ID NCT04788511) diabetes
Moreover, among those who have had bariatric surgery--which we now know produces comparable weight loss--their relative strength goes up and they become more physically capable.In short: There is no reason to think that GLP-1 drugs are make people relatively fatter (they reliably increase the ratio of muscle to fat), more fat than they would be doing something else (no difference), or weaker than they would be losing weight in another way.If you'd like to know more, check out my latest article
Ando S, Tadenuma T, Tanaka Y, Fukui F, Kobayashi S, Ohashi Y, Kawabata T
HGH deficiency has been associated with memory problems, fatigue, sleep disturbances, and attention deficits, which negatively affect individuals emotional wellbeing and quality of life (Nyberg and Mathias Hallberg, 2013